stockrow
Friday 6 November 2026
Export WOK’s income statement to Excel — free account
WORK Medical Technology Group LTD
WOK Healthcare Medical Devices
WORK Medical Technology Group LTD’s revenue for fiscal 2025 (year ended September 2025) was $9.8 million, down 14.4% from fiscal 2024.
0.97
0.05
+5.43%
Follow WOK
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to September
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Mar ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 20 | 20 | 14 | 12 | 10 | — | (15.9%) | — | — | — | — | |
| Gross margin, % | — | — | — | — | — | 22.42 | 22.42 | 30.54 | 24.93 | 23.81 | — | +1.4 pt | ||||||
| EBT | — | — | — | — | — | 1 | 1 | 0 | (4) | (1) | — | n/m | ||||||
| EBT margin, % | — | — | — | — | — | 5.65 | 5.65 | 0.81 | (31.86) | (10.99) | — | (16.6) pt | ||||||
| Net income | — | — | — | — | — | 0 | 1 | 0 | (4) | (1) | (5) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 1.58 | 1.09 | 90.53 | 33.98 | — | n/m | |||||
| Earnings | — | — | — | — | — | — | 0.08 | 0.01 | (27.87) | (4.00) | — | n/m | ||||||
| Cash flow | — | — | — | — | — | — | (0.18) | 0.18 | (17.53) | 21.55 | 0.00 | n/m | ||||||
| Capex | — | — | — | — | — | — | (0.11) | (0.05) | (71.31) | (2.97) | 0.00 | +197.3% | ||||||
| Free cash flow | — | — | — | — | — | — | (0.29) | 0.13 | (88.84) | 18.58 | 0.00 | n/m | ||||||
| Book value | — | — | — | — | — | 0.00 | 0.90 | 0.88 | 126.44 | 73.03 | 0.00 | n/m | ||||||
| Shares, m | — | — | — | — | — | — | 13 | 13 | 0 | 0 | — | (71.5%) | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| P/B | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/Sales | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/FCF | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.44) | (0.24) | (0.15) | (0.1) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | (2) | 2 | (2) | 6 | (9) | n/m | |||||
| Capex | — | — | — | — | — | — | (1) | (1) | (9) | (1) | (13) | (15.2%) | ||||||
| Free cash flow | — | — | — | — | — | — | (4) | 2 | (11) | 5 | (22) | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 2 | 2 | 3 | 1 | 8 | 6 | +37.8% | |||||
| Net debt | — | — | — | — | — | (1) | 5 | 7 | 6 | 2 | 3 | n/m | ||||||
| Shareholders’ equity | — | — | — | — | — | 11 | 11 | 11 | 16 | 21 | 32 | +17.3% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | 3.39 | 0.40 | (10.55) | (3.09) | 0.00 | (3.1) pt | |||||
| ROIC | — | — | — | — | — | 4.93 | 2.43 | 1.42 | (11.27) | (6.65) | 0.00 | (11.6) pt | ||||||
| ROE | — | — | — | — | — | 0.00 | 8.36 | 1.01 | (25.82) | (5.76) | 0.00 | (5.8) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 226 | 216 | 238 | — | +2.6% | |||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.00 | 0.06 | 0.05 | 0.04 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Sep 2025
WORK Medical Technology Group LTD vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| TBIO Telesis Bio Inc. | $5.3M | — (loss-making) | — (loss-making) | −71.85% (below 0%: shrinking) | n/m | −17.96% (below 0%: shrinking) | 64.43% | (349.74%) | Compare |
| VNRX VolitionRX Limited | $5.3M | — (loss-making) | — (loss-making) | −1.97% (below 0%: shrinking) | n/m | +18.58% (above 0%: growing) | 100.00% | (1,042.39%) | Compare |
| BDMD Baird Medical Investment Holdings Limited | $5.0M | — (loss-making) | — | — | n/m | −598.12% (below 0%: shrinking) | — | — | Compare |
| NVNO enVVeno Medical Corporation | $4.8M | — (loss-making) | — (loss-making) | +0.32% (above 0%: growing) | n/m | +27.64% (above 0%: growing) | 0.00% | 0.00% | Compare |
| TNON Tenon Medical, Inc. | $4.4M | — (loss-making) | — (loss-making) | +126.77% (above 0%: growing) | n/m | −21.78% (below 0%: shrinking) | 63.64% | (262.24%) | Compare |
| WOK WORK Medical Technology Group LTD | $4.1M | — | — | — | — | −948.94% (below 0%: shrinking) | — | — | |
| TRIB Trinity Biotech PLC | $3.8M | — (loss-making) | — (loss-making) | +43.28% (above 0%: growing) | n/m | +75.24% (above 0%: growing) | 35.43% | (24.53%) | Compare |
| XAIR Beyond Air, Inc. | $3.6M | — (loss-making) | — (loss-making) | +0.45% (above 0%: growing) | n/m | −9.10% (below 0%: shrinking) | 12.73% | (373.98%) | Compare |
| VVOS Vivos Therapeutics, Inc. | $3.5M | — (loss-making) | — (loss-making) | +34.90% (above 0%: growing) | n/m | +16.44% (above 0%: growing) | 57.31% | (93.63%) | Compare |
| Median of peers | $4.6M | — | — | +0.45% | — | +3.67% | 57.31% | (262.24%) |